Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Evaluate AD Conversion Rate Differences Between High-risk MCI and Low Risk MCI in Real World Setting

NCT03448445 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.

NCT NCT03448445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03448445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Evaluate AD Conversion Rate Differences Between High-risk MCI and Low Risk MCI in Real World Setting
Lead sponsor
Eisai Korea Inc.
Phase
Observational
Overall status
Completed
Start date
June 22, 2018
Completion date
August 10, 2021
Enrollment
201 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment